{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:04:36Z","timestamp":1760609076038},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:00:00Z","timestamp":1534809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunogenetics"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00251-018-1077-z","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:53:06Z","timestamp":1534812786000},"page":"639-646","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The polymorphism at residue 156 determines the HLA-B*35 restricted peptide repertoire during HCMV infection"],"prefix":"10.1007","volume":"70","author":[{"given":"Wiebke C.","family":"Abels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trishna","family":"Manandhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Kunze-Schumacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Blasczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Bade-D\u00f6ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,21]]},"reference":[{"key":"1077_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1055\/s-2006-945530","volume":"27","author":"B Afessa","year":"2006","unstructured":"Afessa B, Peters SG (2006) Major complications following hematopoietic stem cell transplantation. Semin Respir Crit Care Med 27:297\u2013309","journal-title":"Semin Respir Crit Care Med"},{"key":"1077_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S1074-7613(00)80349-0","volume":"6","author":"K Ahn","year":"1997","unstructured":"Ahn K, Gruhler A, Galocha B, Jones TR, Wiertz EJ, Ploegh HL, Peterson PA, Yang Y, Fr\u00fch K (1997) The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6:613\u2013621","journal-title":"Immunity"},{"key":"1077_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3324\/haematol.2010.030924","volume":"96","author":"C Bade-Doding","year":"2011","unstructured":"Bade-Doding C, Theodossis A, Gras S, Kjer-Nielsen L, Eiz-Vesper B, Seltsam A, Huyton T, Rossjohn J, McCluskey J, Blasczyk R (2011) The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family. Haematologica 96:110\u2013118","journal-title":"Haematologica"},{"key":"1077_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3324\/haematol.2011.046037","volume":"97","author":"S Badrinath","year":"2012","unstructured":"Badrinath S, Saunders P, Huyton T, Aufderbeck S, Hiller O, Blasczyk R, Bade-Doeding C (2012) Position 156 influences the peptide repertoire and tapasin dependency of human leukocyte antigen B*44 allotypes. Haematologica 97:98\u2013106","journal-title":"Haematologica"},{"key":"1077_CR5","doi-asserted-by":"publisher","first-page":"298145","DOI":"10.1155\/2014\/298145","volume":"2014","author":"S Badrinath","year":"2014","unstructured":"Badrinath S, Kunze-Schumacher H, Blasczyk R, Huyton T, Bade-Doeding C (2014) A micropolymorphism altering the residue triad 97\/114\/156 determines the relative levels of tapasin independence and distinct peptide profiles for HLA-A(*)24 allotypes. J Immunol Res 2014:298145","journal-title":"J Immunol Res"},{"key":"1077_CR6","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.molimm.2008.12.003","volume":"46","author":"MJ Bell","year":"2009","unstructured":"Bell MJ, Burrows JM, Brennan R, Miles JJ, Tellam J, McCluskey J, Rossjohn J, Khanna R, Burrows SR (2009) The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length. Mol Immunol 46:1911\u20131917","journal-title":"Mol Immunol"},{"key":"1077_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/329512a0","volume":"329","author":"PJ Bjorkman","year":"1987","unstructured":"Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987a) The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329:512\u2013518","journal-title":"Nature"},{"key":"1077_CR8","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/329506a0","volume":"329","author":"PJ Bjorkman","year":"1987","unstructured":"Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987b) Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506\u2013512","journal-title":"Nature"},{"key":"1077_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.it.2005.11.001","volume":"27","author":"SR Burrows","year":"2006","unstructured":"Burrows SR, Rossjohn J, McCluskey J (2006) Have we cut ourselves too short in mapping CTL epitopes? Trends Immunol 27:11\u201316","journal-title":"Trends Immunol"},{"key":"1077_CR10","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/eji.200636588","volume":"37","author":"JM Burrows","year":"2007","unstructured":"Burrows JM, Wynn KK, Tynan FE, Archbold J, Miles JJ, Bell MJ, Brennan RM, Walker S, McCluskey J, Rossjohn J, Khanna R, Burrows SR (2007) The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV. Eur J Immunol 37:946\u2013953","journal-title":"Eur J Immunol"},{"key":"1077_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/rmv.655","volume":"20","author":"MJ Cannon","year":"2010","unstructured":"Cannon MJ, Schmid DS, Hyde TB (2010) Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20:202\u2013213","journal-title":"Rev Med Virol"},{"key":"1077_CR12","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1128\/JVI.73.7.5757-5766.1999","volume":"73","author":"J Chambers","year":"1999","unstructured":"Chambers J, Angulo A, Amaratunga D, Guo H, Jiang Y, Wan JS, Bittner A, Frueh K, Jackson MR, Peterson PA, Erlander MG, Ghazal P (1999) DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J Virol 73:5757\u20135766","journal-title":"J Virol"},{"key":"1077_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jviromet.2010.05.001","volume":"168","author":"M Paschale De","year":"2010","unstructured":"De Paschale M, Agrappi C, Manco MT, Clerici P (2010) Positive predictive value of anti-HCMV IgM as an index of primary infection. J Virol Methods 168:121\u2013125","journal-title":"J Virol Methods"},{"key":"1077_CR14","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1182\/blood-2011-08-371971","volume":"119","author":"E Doubrovina","year":"2012","unstructured":"Doubrovina E, Oflaz-Sozmen B, Prockop SE, Kernan NA, Abramson S, Teruya-Feldstein J, Hedvat C, Chou JF, Heller G, Barker JN, Boulad F, Castro-Malaspina H, George D, Jakubowski A, Koehne G, Papadopoulos EB, Scaradavou A, Small TN, Khalaf R, Young JW, O'Reilly RJ (2012) Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. Blood 119:2644\u20132656","journal-title":"Blood"},{"key":"1077_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF00190906","volume":"38","author":"K Falk","year":"1993","unstructured":"Falk K, R\u00f6tzschke O, Grahovac B, Schendel D, Stevanovi\u0107 S, Jung G, Rammensee HG (1993) Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics 38:161\u2013162","journal-title":"Immunogenetics"},{"key":"1077_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/QCO.0000000000000375","volume":"30","author":"S Fuji","year":"2017","unstructured":"Fuji S, Einsele H, Kapp M (2017) Cytomegalovirus disease in hematopoietic stem cell transplant patients: current and future therapeutic options. Curr Opin Infect Dis 30:372\u2013376","journal-title":"Curr Opin Infect Dis"},{"key":"1077_CR17","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1128\/JVI.76.22.11753-11756.2002","volume":"76","author":"MH Furman","year":"2002","unstructured":"Furman MH, Dey N, Tortorella D, Ploegh HL (2002) The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules. J Virol 76:11753\u201311756","journal-title":"J Virol"},{"key":"1077_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1182\/blood.V97.4.835","volume":"97","author":"S Gottschalk","year":"2001","unstructured":"Gottschalk S, Ng CYC, Perez M, Smith CA, Sample C, Brenner MK, Heslop HE, Rooney CM (2001) An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs. Blood 97:835\u2013843","journal-title":"Blood"},{"key":"1077_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/360364a0","volume":"360","author":"H-C Guo","year":"1992","unstructured":"Guo H-C, Jardetzky TS, Garrettt TPJ, Lane WS, Strominger JL, Wiley DC (1992) Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 360:364\u2013366","journal-title":"Nature"},{"key":"1077_CR20","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1073\/pnas.95.7.3937","volume":"95","author":"G Hahn","year":"1998","unstructured":"Hahn G, Jores R, Mocarski ES (1998) Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A 95:3937\u20133942","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1077_CR21","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1128\/JVI.01923-10","volume":"85","author":"A Halenius","year":"2011","unstructured":"Halenius A, Hauka S, Dolken L, Stindt J, Reinhard H, Wiek C, Hanenberg H, Koszinowski UH, Momburg F, Hengel H (2011) Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcription. J Virol 85:3473\u20133485","journal-title":"J Virol"},{"key":"1077_CR22","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/360434a0","volume":"360","author":"AV Hill","year":"1992","unstructured":"Hill AV, Elvin J, Willis AC, Aidoo M, Allsopp CE, Gotch FM, Gao XM, Takiguchi M, Greenwood BM, Townsend AR, McMichael AJ, Whittle HC (1992) Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434\u2013439","journal-title":"Nature"},{"key":"1077_CR23","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.4049\/jimmunol.151.5.2572","volume":"151","author":"EL Huczko","year":"1993","unstructured":"Huczko EL, Bodnar WM, Benjamin D, Sakaguchi K, Zhu N, Shabanowitz J, Henderson RA, Appella E, Hunt DF, Engelhard VH (1993) Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J Immunol 151:2572\u20132587","journal-title":"J Immunol"},{"key":"1077_CR24","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1126\/science.1546328","volume":"255","author":"DF Hunt","year":"1992","unstructured":"Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, Cox AL, Appella E, Engelhard VH (1992) Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261\u20131263","journal-title":"Science"},{"key":"1077_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1399-0039.2012.01928.x","volume":"80","author":"T Huyton","year":"2012","unstructured":"Huyton T, Ladas N, Schumacher H, Blasczyk R, Bade-Doeding C (2012) Pocketcheck: updating the HLA class I peptide specificity roadmap. Tissue Antigens 80:239\u2013248","journal-title":"Tissue Antigens"},{"key":"1077_CR26","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1128\/JVI.71.4.2970-2979.1997","volume":"71","author":"TR Jones","year":"1997","unstructured":"Jones TR, Sun L (1997) Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J Virol 71:2970\u20132979","journal-title":"J Virol"},{"key":"1077_CR27","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1128\/JVI.69.8.4830-4841.1995","volume":"69","author":"TR Jones","year":"1995","unstructured":"Jones TR, Hanson LK, Sun L, Slater JS, Stenberg RM, Campbell AE (1995) Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J Virol 69:4830\u20134841","journal-title":"J Virol"},{"key":"1077_CR28","doi-asserted-by":"publisher","first-page":"11327","DOI":"10.1073\/pnas.93.21.11327","volume":"93","author":"TR Jones","year":"1996","unstructured":"Jones TR, Wiertz EJ, Sun L, Fish KN, Nelson JA, Ploegh HL (1996) Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A 93:11327\u201311333","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1077_CR29","doi-asserted-by":"publisher","first-page":"e1000123","DOI":"10.1371\/journal.ppat.1000123","volume":"4","author":"Y Kim","year":"2008","unstructured":"Kim Y, Park B, Cho S, Shin J, Cho K, Jun Y, Ahn K (2008) Human cytomegalovirus UL18 utilizes US6 for evading the NK and T-cell responses. PLoS Pathog 4:e1000123","journal-title":"PLoS Pathog"},{"key":"1077_CR30","doi-asserted-by":"publisher","first-page":"346714","DOI":"10.1155\/2015\/346714","volume":"2015","author":"T Kraemer","year":"2015","unstructured":"Kraemer T, Celik AA, Huyton T, Kunze-Schumacher H, Blasczyk R, Bade-Doding C (2015) HLA-E: presentation of a broader peptide repertoire impacts the cellular immune response-implications on HSCT outcome. Stem Cells Int 2015:346714","journal-title":"Stem Cells Int"},{"key":"1077_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev.iy.08.040190.000323","volume":"8","author":"DA Lawlor","year":"1990","unstructured":"Lawlor DA, Zemmour J, Ennis PD, Parham P (1990) EVOLUTION OF CLASS-I MHC GENES AND PROTEINS: from natural selection to Thymic selection. Annu Rev Immunol 8:23\u201363","journal-title":"Annu Rev Immunol"},{"key":"1077_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00251-015-0896-4","volume":"68","author":"T Manandhar","year":"2016","unstructured":"Manandhar T, Kunze-Schumacher H, Huyton T, Celik AA, Blasczyk R, Bade-Doeding C (2016) Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes. Immunogenetics 68:247\u2013260","journal-title":"Immunogenetics"},{"key":"1077_CR33","doi-asserted-by":"crossref","unstructured":"McMurtrey C, Trolle T, Sansom T, Remesh SG, Kaever T, Bardet W, Jackson K, McLeod R, Sette A, Nielsen M, Zajonc DM, Blader IJ, Peters B, Hildebrand W (2016) Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove. Elife 5","DOI":"10.7554\/eLife.12556"},{"key":"1077_CR34","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1099\/0022-1317-77-12-3099","volume":"77","author":"M Mendelson","year":"1996","unstructured":"Mendelson M, Monard S, Sissons P, Sinclair J (1996) Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol 77:3099\u20133102","journal-title":"J Gen Virol"},{"key":"1077_CR35","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.4049\/jimmunol.177.10.6804","volume":"177","author":"JJ Miles","year":"2006","unstructured":"Miles JJ, Borg NA, Brennan RM, Tynan FE, Kjer-Nielsen L, Silins SL, Bell MJ, Burrows JM, McCluskey J, Rossjohn J, Burrows SR (2006) TCR genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope. J Immunol 177:6804\u20136814","journal-title":"J Immunol"},{"key":"1077_CR36","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/infdis\/jix357","volume":"216","author":"XY Pei","year":"2017","unstructured":"Pei XY, Zhao XY, Chang YJ, Liu J, Xu LP, Wang Y, Zhang XH, Han W, Chen YH, Huang XJ (2017) Cytomegalovirus-specific T-cell transfer for refractory cytomegalovirus infection after Haploidentical stem cell transplantation: the quantitative and qualitative immune recovery for cytomegalovirus. J Infect Dis 216:945\u2013956","journal-title":"J Infect Dis"},{"key":"1077_CR37","doi-asserted-by":"publisher","first-page":"5610","DOI":"10.4049\/jimmunol.173.9.5610","volume":"173","author":"M Probst-Kepper","year":"2004","unstructured":"Probst-Kepper M, Hecht HJ, Herrmann H, Janke V, Ocklenburg F, Klempnauer J, van den Eynde BJ, Weiss S (2004) Conformational restraints and flexibility of 14-Meric peptides in complex with HLA-B*3501. J Immunol 173:5610\u20135616","journal-title":"J Immunol"},{"key":"1077_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1146\/annurev.iy.11.040193.001241","volume":"11","author":"HG Rammensee","year":"1993","unstructured":"Rammensee HG, Falk K, R\u00f6tzschke O (1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11:213\u2013244","journal-title":"Annu Rev Immunol"},{"key":"1077_CR39","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.1074\/jbc.M117.776542","volume":"292","author":"SG Remesh","year":"2017","unstructured":"Remesh SG, Andreatta M, Ying G, Kaever T, Nielsen M, McMurtrey C, Hildebrand W, Peters B, Zajonc DM (2017) Unconventional peptide presentation by major histocompatibility complex (MHC) class I allele HLA-A*02:01: BREAKING CONFINEMENT. J Biol Chem 292:5262\u20135270","journal-title":"J Biol Chem"},{"key":"1077_CR40","doi-asserted-by":"publisher","first-page":"D423","DOI":"10.1093\/nar\/gku1161","volume":"43","author":"J Robinson","year":"2015","unstructured":"Robinson J, Halliwell JA, Hayhurst JD, Flicek P, Parham P, Marsh SG (2015) The IPD and IMGT\/HLA database: allele variant databases. Nucleic Acids Res 43:D423\u2013D431","journal-title":"Nucleic Acids Res"},{"key":"1077_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/sj.bmt.1705671","volume":"40","author":"J Ruell","year":"2007","unstructured":"Ruell J, Barnes C, Mutton K, Foulkes B, Chang J, Cavet J, Guiver M, Menasce L, Dougal M, Chopra R (2007) Active CMV disease does not always correlate with viral load detection. Bone Marrow Transplant 40:55\u201361","journal-title":"Bone Marrow Transplant"},{"key":"1077_CR42","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1537-2995.2010.02940.x","volume":"51","author":"A Schmitt","year":"2011","unstructured":"Schmitt A, Tonn T, Busch DH, Grigoleit GU, Einsele H, Odendahl M, Germeroth L, Ringhoffer M, Ringhoffer S, Wiesneth M, Greiner J, Michel D, Mertens T, Rojewski M, Marx M, von Harsdorf S, Dohner H, Seifried E, Bunjes D, Schmitt M (2011) Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion 51:591\u2013599","journal-title":"Transfusion"},{"key":"1077_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s002510050179","volume":"45","author":"C Sch\u00f6nbach","year":"1996","unstructured":"Sch\u00f6nbach C, Miwa K, Ibe M, Shiga H, Nokihara K, Takiguchi M (1996) Refined peptide HLA-B*3501 binding motif reveals differences in 9-mer to 11-mer peptide binding. Immunogenetics 45:121\u2013129","journal-title":"Immunogenetics"},{"key":"1077_CR44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00430-015-0415-0","volume":"204","author":"JG Sissons","year":"2015","unstructured":"Sissons JG, Wills MR (2015) How understanding immunology contributes to managing CMV disease in immunosuppressed patients: now and in future. Med Microbiol Immunol 204:307\u2013316","journal-title":"Med Microbiol Immunol"},{"key":"1077_CR45","doi-asserted-by":"publisher","first-page":"7829","DOI":"10.1073\/pnas.141108798","volume":"98","author":"A Skaletskaya","year":"2001","unstructured":"Skaletskaya A, Bartle LM, Chittenden T, McCormick AL, Mocarski ES, Goldmacher VS (2001) A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A 98:7829\u20137834","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1077_CR46","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.4049\/jimmunol.175.4.2459","volume":"175","author":"GBE Stewart-Jones","year":"2005","unstructured":"Stewart-Jones GBE, Gillespie G, Overton IM, Kaul R, Roche P, McMichael AJ, Rowland-Jones S, Jones EY (2005) Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression. J Immunol 175:2459\u20132468","journal-title":"J Immunol"},{"key":"1077_CR47","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jcyt.2017.07.012","volume":"19","author":"G Sutrave","year":"2017","unstructured":"Sutrave G, Blyth E, Gottlieb DJ (2017) Cellular therapy for multiple pathogen infections after hematopoietic stem cell transplant. Cytotherapy 19:1284\u20131301","journal-title":"Cytotherapy"},{"key":"1077_CR48","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1099\/0022-1317-72-9-2059","volume":"72","author":"J Taylor-Wiedeman","year":"1991","unstructured":"Taylor-Wiedeman J, Sissons JGP, Borysiewicz LK, Sinclair JH (1991) Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 72:2059\u20132064","journal-title":"J Gen Virol"},{"key":"1077_CR49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1743-422X-9-22","volume":"9","author":"JP Tomtishen 3rd","year":"2012","unstructured":"Tomtishen JP 3rd (2012) Human cytomegalovirus tegument proteins (pp65, pp71, pp150, pp28). Virol J 9:22","journal-title":"Virol J"},{"key":"1077_CR50","doi-asserted-by":"publisher","first-page":"23900","DOI":"10.1074\/jbc.M503060200","volume":"280","author":"FE Tynan","year":"2005","unstructured":"Tynan FE, Borg NA, Miles JJ, Beddoe T, El-Hassen D, Silins SL, van Zuylen WJ, Purcell AW, Kjer-Nielsen L, McCluskey J, Burrows SR, Rossjohn J (2005a) High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance. J Biol Chem 280:23900\u201323909","journal-title":"J Biol Chem"},{"key":"1077_CR51","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/ni1257","volume":"6","author":"FE Tynan","year":"2005","unstructured":"Tynan FE, Burrows SR, Buckle AM, Clements CS, Borg NA, Miles JJ, Beddoe T, Whisstock JC, Wilce MC, Silins SL, Burrows JM, Kjer-Nielsen L, Kostenko L, Purcell AW, McCluskey J, Rossjohn J (2005b) T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat Immunol 6:1114\u20131122","journal-title":"Nat Immunol"},{"key":"1077_CR52","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1084\/jem.20050864","volume":"202","author":"FE Tynan","year":"2005","unstructured":"Tynan FE, Elhassen D, Purcell AW, Burrows JM, Borg NA, Miles JJ, Williamson NA, Green KJ, Tellam J, Kjer-Nielsen L, McCluskey J, Rossjohn J, Burrows SR (2005c) The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. J Exp Med 202:1249\u20131260","journal-title":"J Exp Med"},{"key":"1077_CR53","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/bloodadvances.2017010223","volume":"1","author":"B Withers","year":"2017","unstructured":"Withers B, Blyth E, Clancy LE, Yong A, Fraser C, Burgess J, Simms R, Brown R, Kliman D, Dubosq M-C, Bishop D, Sutrave G, Ma CKK, Shaw PJ, Micklethwaite KP, Gottlieb DJ (2017) Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells. Blood Adv 1:2193\u20132205","journal-title":"Blood Adv"},{"key":"1077_CR54","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1182\/blood-2007-11-122622","volume":"111","author":"KK Wynn","year":"2008","unstructured":"Wynn KK, Fulton Z, Cooper L, Silins SL, Gras S, Archbold JK, Tynan FE, Miles JJ, McCluskey J, Burrows SR, Rossjohn J, Khanna R (2008) Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection. Blood 111:4283\u20134292","journal-title":"Blood"}],"container-title":["Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00251-018-1077-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-018-1077-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-018-1077-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T13:13:06Z","timestamp":1693833186000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00251-018-1077-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,21]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1077"],"URL":"https:\/\/doi.org\/10.1007\/s00251-018-1077-z","relation":{},"ISSN":["0093-7711","1432-1211"],"issn-type":[{"value":"0093-7711","type":"print"},{"value":"1432-1211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,21]]},"assertion":[{"value":"12 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}